Immediate Impact

2 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Repression of the aryl-hydrocarbon receptor prevents oxidative stress and ferroptosis of intestinal intraepithelial lymphocytes
2023 Standout
1 intermediate paper

Works of Nasséra Chalabi being referenced

LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)
2023
Resveratrol and breast cancer chemoprevention: Molecular mechanisms
2005

Author Peers

Author Last Decade Papers Cites
Nasséra Chalabi 226 373 153 183 36 805
Jae Young So 319 430 156 194 24 936
Kestutis Planutis 162 634 68 126 22 921
Maria Simonsson 261 510 152 214 27 903
Hye‐Sook Seo 170 519 154 121 26 902
Mani Menon 125 331 139 94 37 957
Zbigniew Banaszkiewicz 193 425 109 137 38 832
Erik Kúdela 183 461 62 253 52 972
Daniele G. Soares 272 436 38 147 29 806
Jianguo Cao 235 525 41 162 55 863
Oana Zănoagă 133 517 38 283 46 865

All Works

Loading papers...

Rankless by CCL
2026